Product Code: QTD FDA class 2 21 CFR 876.5983

Endoscopic Suturing Device For Altering Gastric Anatomy For Weight Loss

Gastroenterology, Urology

The Endoscopic Suturing Device for Altering Gastric Anatomy for Weight Loss is a device used endoscopically to apply sutures that approximate and fold gastric tissue, restricting stomach volume and reducing caloric intake for the treatment of obesity. Unlike bariatric surgery, this approach is entirely endoscopic. Classified as FDA Class 2 under regulation 876.5983, it requires 510(k) clearance in the Gastroenterology and Urology specialty, and is flagged as an implant because the sutures remain in place in the gastric wall. It is not life-sustaining.

510(k)s
2
FEI Numbers
5
Registration Numbers
5
Unique Applicants
2
Years Active
1

Basic Information

Product Code
QTD
Device Class
FDA class 2
Regulation Number
876.5983
Medical Specialty
Gastroenterology, Urology
Review Panel
GU
Submission Type
1

Device Characteristics

GMP Exempt
Implant
Life Sustain/Support
Third Party
Summary Malfunction Reporting

Definition

This endoscopic device uses suturing to approximate gastric tissue to restrict the volume of the stomach for the intended purpose of weight loss.

510(k) Clearance History

Loading...

Related 510(k) Clearances

This FDA classification is associated with 2 510(k) clearances via K numbers.

K Number Device Name
K232544 Apollo ESG NXT System, Apollo REVISE NXT System
DEN210045 APOLLO ESG System, APOLLO ESG SX System, APOLLO REVISE System, APOLLO REVISE SX System

FEI Numbers

This FDA classification entry is associated with 5 FEI numbers. Click on an entry to view related FDA registrations.

Registration Numbers

This FDA classification entry is associated with 5 registration numbers. Click on an entry to view related FDA registrations.